High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Bone

• Publication date

  2008-06-01

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1016/j.bone.2008.02.006PMID 18378205PMCID PMC2696157
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis

  2007cited by this paper
• Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice.

  2007cited by this paper
• Non-enzymatic Glycation of Bone Collagen Modifies Osteoclastic Activity and Differentiation*

  2007cited by this paper
• Homocysteine Enhances Bone Resorption by Stimulation of Osteoclast Formation and Activity Through Increased Intracellular ROS Generation

  2006cited by this paper
• Arachidonic Acid–Dependent Activation of a p22phox-Based NAD(P)H Oxidase Mediates Angiotensin II–Induced Mesangial Cell Protein Synthesis and Fibronectin Expression via Akt/PKB

  2006cited by this paper
• Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non‐osmotic pathways

  2006cited by this paper
• MMP-9 antisense oligodeoxynucleotide exerts an inhibitory effect on osteoclastic bone resorption by suppressing cell migration.

  2006cited by this paper
• Active caspase‐3 is required for osteoclast differentiation

  2006influential reference
• Hyperglycemia-Induced Reactive Oxygen Species and Impaired Endothelial Progenitor Cell Function

  2005cited by this paper
• A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation.

  2005cited by this paper
• Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice.

  2005cited by this paper
• Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues.

  2005cited by this paper
• Nox4 NAD(P)H Oxidase Mediates Hypertrophy and Fibronectin Expression in the Diabetic Kidney*

  2005cited by this paper
• Reactive Oxygen Species Stimulates Receptor Activator of NF-κB Ligand Expression in Osteoblast*

  2005cited by this paper
• Reactive oxygen species mediate RANK signaling in osteoclasts.

  2004cited by this paper
• Modulation of osteoblast activity by serum from diabetic and non-diabetic patients on hemodialysis: a three-dimensional culture study.

  2004cited by this paper
• Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities.

  2004cited by this paper
• Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling.

  2003cited by this paper
• IkappaBalpha-dependent regulation of low-shear flow-induced NF-kappa B activity: role of nitric oxide.

  2003cited by this paper
• Stromal Cell‐Derived Factor‐1 (SDF‐1) Recruits Osteoclast Precursors by Inducing Chemotaxis, Matrix Metalloproteinase‐9 (MMP‐9) Activity, and Collagen Transmigration

  2003cited by this paper
• IκBα-dependent regulation of low-shear flow-induced NF-κB activity: role of nitric oxide

  2003cited by this paper
• Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities

  2003cited by this paper
• Molecular motors

  2003cited by this paper
• Regulation of osteoclast protease expression by RANKL.

  2003cited by this paper
• Reactive oxygen intermediates in TNF signaling.

  2002cited by this paper
• Glucose-induced inhibition of in vitro bone mineralization.

  2001cited by this paper
• Angiotensin II activates Akt/protein kinase B by an arachidonic acid/redox‐dependent pathway and independent of phosphoinositide 3‐kinase

  2001cited by this paper
• The role of oxidative stress in the onset and progression of diabetes and its complications: asummary of a Congress Series sponsored byUNESCO‐MCBN, the American Diabetes Association and the German Diabetes Society

  2001cited by this paper
• Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells: possible role in diabetic nephropathy.

  2000cited by this paper
• Extracellular glucose influences osteoblast differentiation and c–jun expression

  2000cited by this paper
• Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology

  2000cited by this paper
• Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.

  1999cited by this paper
• The Ligand for Osteoprotegerin (OPGL) Directly Activates Mature Osteoclasts

  1999cited by this paper
• OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

  1999cited by this paper
• Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

  1999cited by this paper
• Growth-inhibitory effect of a high glucose concentration on osteoblast-like cells.

  1998cited by this paper
• Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

  1998cited by this paper
• The Migration of Purified Osteoclasts Through Collagen Is Inhibited by Matrix Metalloproteinase Inhibitors

  1998cited by this paper
• Comparative studies of rat recombinant purple acid phosphatase and bone tartrate-resistant acid phosphatase.

  1997cited by this paper
• Regulation of osteoclastic bone resorption by glucose.

  1997cited by this paper
• Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones.

  1995cited by this paper
• Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts.

  1994cited by this paper
• Participation of oxidative stress in the process of osteoclast differentiation.

  1993cited by this paper
• Diabetes mellitus and bone metabolism.

  1992cited by this paper
• Modulation of osteoclast differentiation.

  1992cited by this paper
• Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo.

  1990cited by this paper
• A prospective study of bone mass in patients with type I diabetes.

  1985cited by this paper

• Upregulation of Parathyroid Hormone Receptor 1 (PTH1R) in Non-Mechanostimulated Osteocytes Under High-Glucose Conditions Promotes a Macrophage Pro-Inflammatory and Osteoclastogenic Phenotype via IL-6 Secretion.

  2026cites this paper
• Breaking the vicious cycle: Multifunctional nanomaterials targeting Tumor metabolic reprogramming to overcome T cell exhaustion and bone repair failure in bone tumors

  2025cites this paper
• A trend of osteocalcin in diabetes mellitus research: bibliometric and visualization analysis

  2025cites this paper
• The Role of Autophagy in the Regulation of Bidirectional Relationships in Diabetic Periodontitis

  2025cites this paper
• Scavenging methylglyoxal improves bone quality and defect healing in diabetic mice

  2025cites this paper
• Association between surrogate marker of insulin resistance and bone mineral density in US adults without diabetes

  2024cites this paper
• Effects of Methotrexate, Moringa Leaf (Moringa oleifera) Extract, and Sambiloto Leaf (Andrographis paniculata) Extract on Blood Glucose Levels, Interleukin-6 Levels, and Trabecular Density in Streptozotocin-Nicotinamide-Induced Hyperglycemic Rodents

  2024cites this paper
• Association of bone turnover markers with glucose metabolism in type 2 diabetes mellitus

  2024cites this paper
• Renal Osteodystrophy and Bone Biopsy

  2023cites this paper
• Low Bone Turnover Associates With Lower Insulin Sensitivity in Newly Diagnosed Drug-Naïve Persons With Type 2 Diabetes

  2023cites this paper
• Type 2 Diabetes and Bone Disease

  2023cites this paper
• Biochemical Markers of Bone Fragility in Patients With Diabetes

  2023cites this paper
• Suppression of TLR4 prevents diabetic bone loss by regulating FTO-mediated m6A modification.

  2023cites this paper
• Association Analysis of Triglyceride Glucose-Body Mass Index and Bone Turnover Markers in Patients with Type 2 Diabetes Mellitus

  2023cites this paper
• Relationship between Diabetes Mellitus and Root Canal Infections

  2023cites this paper
• The bidirectional association between diabetes and periodontitis, from basic to clinical

  2023cites this paper
• Determinants of Low Bone Turnover in Type 2 Diabetes-the Role of PTH

  2022cites this paper
• Metabolic and physiological effects of insulin

  2022cites this paper
• Age- and obesity-related metabolic changes and their impact on the incidence of digestion, metabolism, and immune health

  2022cites this paper
• Effect of inflammation on bones in diabetic patients with periodontitis via RANKL/OPG system-A review

  2022influential citation
• Formononetin attenuates osteoclast differentiation and calcium loss by mediating transcription factor AP‐1 in type I diabetic mice

  2022cites this paper
• Prediction of Femoral Strength Based on Bone Density and Biochemical Markers in Elderly Men With Type 2 Diabetes Mellitus

  2022cites this paper
• Bone Density, Geometry, and Mass by Peripheral Quantitative Computed Tomography and Bone Turnover Markers in Children with Diabetes Mellitus Type 1

  2022cites this paper
• Effects of Type 2 Diabetes Mellitus on Osteoclast Differentiation, Activity, and Cortical Bone Formation in POSTmenopausal MRONJ Patients

  2022cites this paper
• Fracture risk assessment in diabetes mellitus

  2022cites this paper
• Xianling Gubao attenuates high glucose-induced bone metabolism disorder in MG63 osteoblast-like cells

  2022cites this paper
• High glucose impairs osteogenic differentiation of embryonic stem cells via early diversion of beta‐catenin from Forkhead box O to T cell factor interaction

  2022cites this paper
• A Critical Analysis of Relationship and Management of Sweet Bones in Insulin-Dependent Diabetes Mellitus

  2022cites this paper
• The amelioration of T2DM rat femoral bone achieved by anti-osteoporosis of caprine CSN1S2 protein through bone morphogenetic protein signaling pathway.

  2021cites this paper
• 3D Environment Is Required In Vitro to Demonstrate Altered Bone Metabolism Characteristic for Type 2 Diabetics

  2021cites this paper
• Bone quality analysis of jaw bones in individuals with type 2 diabetes mellitus—post mortem anatomical and microstructural evaluation

  2021cites this paper
• PPARβ/δ Agonist Alleviates Diabetic Osteoporosis via Regulating M1/M2 Macrophage Polarization

  2021cites this paper
• Femur absorptiometry changes determined by X-ray image segmentation in mice under experimental diabetes and ovariectomy.

  2021cites this paper
• Native Collagen II Relieves Bone Impairment through Improving Inflammation and Oxidative Stress in Ageing db/db Mice

  2021cites this paper
• Hexosamine Biosynthetic Pathway-Derived O-GlcNAcylation Is Critical for RANKL-Mediated Osteoclast Differentiation

  2021cites this paper
• The role of RANKL and FGF23 in Assessing Bone Turnover in Type 2 Diabetic Patients.

  2021cites this paper
• Quantitative proteomics reveals the effect of Yigu decoction (YGD) on protein expression in bone tissue

  2021cites this paper
• The Role of Osteoclast Energy Metabolism in the Occurrence and Development of Osteoporosis

  2021cites this paper
• PPARβ/δ accelerates bone regeneration in diabetic mellitus by enhancing AMPK/mTOR pathway-mediated autophagy

  2021cites this paper
• Diabetes Mellitus and Osteoporosis Correlation: Challenges and Hopes.

  2020cites this paper
• Bone mineral density and bone metabolism in postmenopausal women with type 2 diabetes in a Chinese community: a cross-sectional study

  2020cites this paper
• Diabetes mellitus—Infections and fracture healing

  2020cites this paper
• Diabetes and bone

  2020cites this paper
• Administration of Human Non-Diabetic Mesenchymal Stromal Cells to a Murine Model of Diabetic Fracture Repair: A Pilot Study

  2020cites this paper
• Role of Altered Metabolic Microenvironment in Osteolytic Metastasis

  2020cites this paper
• Diabetes mellitus: How being too sweet leads to skeletal fragility

  2020cites this paper
• Coumarin Ameliorates Impaired Bone Turnover by Inhibiting the Formation of Advanced Glycation End Products in Diabetic Osteoblasts and Osteoclasts

  2020cites this paper
• Review of Secondary Causes of Osteoporotic Fractures Due to Diabetes and Spinal Cord Injury

  2020cites this paper
• Impact of diabetes mellitus simulations on bone cell behavior through in vitro models

  2020cites this paper
• Human Enriched Serum Following Hydrolysed Collagen Absorption Modulates Bone Cell Activity: from Bedside to Bench and Vice Versa

  2019cites this paper
• Osteoclasts in bone regeneration under type 2 diabetes mellitus.

  2019cites this paper
• Oxidative stress as a possible therapeutic target for osteoporosis associated with aging

  2019cites this paper
• Anomalous bone changes in ovariectomized type-2 diabetic rats: inappropriately low bone turnover with bone loss in an estrogen-deficient condition.

  2019cites this paper
• Lentiviral-mediated Shh reverses the adverse effects of high glucose on osteoblast function and promotes bone formation via Sonic hedgehog signaling

  2019cites this paper
• Bone health in diabetes and prediabetes

  2019cites this paper
• Impact of Diabetes Mellitus on Bone Health

  2019cites this paper
• Inhibition of the negative effect of high glucose on osteogenic differentiation of bone marrow stromal cells by silicon ions from calcium silicate bioceramics

  2019cites this paper
• Biochemical Markers of Bone Turnover and Risk of Incident Diabetes in Older Women: The Cardiovascular Health Study

  2018cites this paper
• Transcriptional activation of glucose transporter 1 in orthodontic tooth movement-associated mechanical response

  2018cites this paper
• Advanced Glycation End Products and esRAGE Are Associated With Bone Turnover and Incidence of Hip Fracture in Older Men

  2018cites this paper
• Skeletal Fragility in Type 2 Diabetes Mellitus

  2018cites this paper
• Effects of metformin, rosiglitazone and insulin on bone metabolism in patients with type 2 diabetes.

  2018cites this paper
• Relación bidireccional entre diabetes mellitus y periodontitis apical.

  2018cites this paper
• Scalable production of tissue engineered microunits for bone regeneration using bioactive glass microspheres and dynamic culture conditions

  2018cites this paper
• The Impact of Type 2 Diabetes on Bone Fracture Healing

  2018cites this paper
• Bone and Diabetes

  2018cites this paper
• SIRT1 suppresses high glucose and palmitate-induced osteoclast differentiation via deacetylating p66Shc.

  2018cites this paper
• Zinc in Postmenopausal Bone Loss

  2018cites this paper
• High glucose downregulates the effects of autophagy on osteoclastogenesis via the AMPK/mTOR/ULK1 pathway.

  2018cites this paper
• Diabetes mellitus and bone health: epidemiology, etiology and implications for fracture risk stratification

  2018cites this paper
• Syddansk Universitet Effects of metformin , rosiglitazone and insulin on bone metabolism in patients with type 2 diabetes

  2018cites this paper
• Hyperglycemia Induces Osteoclastogenesis and Bone Destruction Through the Activation of Ca2+/Calmodulin-Dependent Protein Kinase II

  2018cites this paper
• l-Quebrachitol Promotes the Proliferation, Differentiation, and Mineralization of MC3T3-E1 Cells: Involvement of the BMP-2/Runx2/MAPK/Wnt/β-Catenin Signaling Pathway

  2018cites this paper
• Zoledronate and high glucose levels influence osteoclast differentiation and bone absorption via the AMPK pathway.

  2018cites this paper
• From macrophage to osteoclast – How metabolism determines function and activity

  2018cites this paper
• Angiotensin II/Angiotensin II Receptor Blockade Affects Osteoporosis via the AT1/AT2-Mediated cAMP-Dependent PKA Pathway

  2017cites this paper
• Metabolic properties of the osteoclast.

  2017cites this paper
• Involvement of FAK-mediated BMP-2/Smad pathway in mediating osteoblast adhesion and differentiation on nano-HA/chitosan composite coated titanium implant under diabetic conditions.

  2017cites this paper
• High glucose alters the secretome of mechanically stimulated osteocyte‐like cells affecting osteoclast precursor recruitment and differentiation

  2017influential citation
• Hyperglycemia Suppresses RANKL-Induced Osteoclast Differentiation through LXRβ Expression in RAW264.7 Cells.

  2017cites this paper
• High glucose impaired estrogen receptor alpha signaling via β-catenin in osteoblastic MC3T3-E1.

  2017cites this paper
• Succinate and its G-protein-coupled receptor stimulates osteoclastogenesis

  2017cites this paper
• PTHrP‐Derived Peptides Restore Bone Mass and Strength in Diabetic Mice: Additive Effect of Mechanical Loading

  2017cites this paper
• Osteocalcin favoring glucose control is associated with decreased total hip bone mineral density-evidence from a cross-sectional study in T 2 DM male patients

  2017cites this paper
• MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis.

  2017cites this paper
• Pathophysiology of Bone Fragility in Patients with Diabetes

  2017cites this paper
• Glucose metabolism in bone.

  2017cites this paper
• High glucose‐induced LIF suppresses osteoblast differentiation via regulating STAT3/SOCS3 signaling

  2017cites this paper
• 1α,25-Dihydroxyvitamin D3 promotes osteogenesis by promoting Wnt signaling pathway.

  2017cites this paper
• Bradykinin receptors and EphB2/EphrinB2 pathway in response to high glucose‑induced osteoblast dysfunction and hyperglycemia‑induced bone deterioration in mice

  2016cites this paper
• Bone Marrow Stem Cells and Bone Turnover in Diabetic Disease

  2016cites this paper
• The diabetic paradox: Bone mineral density and fracture in type 2 diabetes.

  2016cites this paper
• Bradykinin receptors and EphB2/EphrinB2 pathway in response to high glucose-induced osteoblast dysfunction and hyperglycemia-induced bone deterioration in mice

  2016cites this paper
• Sulfated hyaluronan improves bone regeneration of diabetic rats by binding sclerostin and enhancing osteoblast function.

  2016cites this paper
• A new perspective on mechanisms governing skeletal complications in type 1 diabetes

  2016cites this paper
• The diabetic paradox: Bone mineral density and fracture in type 2 diabetes.

  2016cites this paper
• Diabetes Stimulates Osteoclastogenesis by Acidosis-Induced Activation of Transient Receptor Potential Cation Channels

  2016cites this paper
• Oxidative stress as a possible therapeutic target for osteoporosis associated with aging

  2016cites this paper
• La paradoja diabética: densidad mineral ósea y fractura en la diabetes tipo 2

  2016cites this paper
• Low bone turnover and reduced angiogenesis in streptozotocin-induced osteoporotic mice

  2016cites this paper